A phase II study of RO4929097 (RO), a gamma-secretase inhibitor, in advanced platinum (Pt)-resistant (R) ovarian cancer (OC): A study of the PMH, Chicago, and California phase II consortia Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Diaz-Padilla, Ivan
  • Clarke, Blaise A
  • Hirte, Holger
  • Welch, Stephen
  • Mackay, Helen
  • Biagi, James Joseph
  • Reedijk, Michael
  • Weberpals, Johanne Ingrid
  • Fleming, Gini F
  • Wang, Lisa
  • Li, Jennifer
  • Strevel, Elizabeth Laureen
  • Eisenhauer, Anne
  • Ivy, S Percy
  • Oza, Amit M

publication date

  • May 20, 2012